Likewise, individuals with mild cognitive impairment exhibited greater availability of α7-nAChR relative to cognitively intact individuals of similar age [36], highlighting the potential role of α7-nAChR as a possible marker for cognitive decline and a potential therapeutic target for age-related and neurodegenerative conditions. This evidence concerns the gene CHRNA7 and Cognitive impairment.